Coco Enterprises, LLC Amgen Inc Transaction History

Coco Enterprises, LLC

$160 Million
Q3 2024

A detailed history of Coco Enterprises, LLC transactions in Amgen Inc stock. As of the latest transaction made, Coco Enterprises, LLC holds 2,624 shares of AMGN stock, worth $734,903. This represents 0.53% of its overall portfolio holdings.

Number of Shares

2,624

Previous 2,789 5.92%

Holding current value

$734,903

Previous $871,000 2.99%

% of portfolio

0.53%

Previous 0.57%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $51,047 - $55,667	-165 Reduced 5.92%	2,624 $845,000
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $16,132 - $19,473	60 Added 2.2%	2,789 $792,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $17,643 - $19,903	-69 Reduced 2.47%	2,729 $786,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $9,839 - $12,215	45 Added 1.63%	2,798 $751,000
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $14,141 - $16,722	66 Added 2.46%	2,753 $611,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $27,997 - $34,124	124 Added 4.84%	2,687 $649,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $9,390 - $11,931	-41 Reduced 1.57%	2,563 $673,000
Q3 2022 Nov 18, 2022	BUY	$224.46 - $253.15 $15,712 - $17,720	70 Added 2.76%	2,604 $591,000
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $18,226 - $20,282	-79 Reduced 3.02%	2,534 $617,000
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $147,130 - $162,764	671 Added 34.55%	2,613 $636,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $11,535 - $13,200	58 Added 3.08%	1,942 $437,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $96,795 - $113,407	456 Added 31.93%	1,884 $401,000
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $333,552 - $370,051	1,428 New	1,428 $351,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coco Enterprises, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coco Enterprises, LLC with notifications on news.

Account

Coco Enterprises, LLC Amgen Inc Transaction History